China's stockmarket gets ready to roar
Chinese stockmarkets had a terrible 2021, but with China's central bank easing monetary policy, 2022 could be much better.

“As the Chinese year of the tiger begins, the… market is set to really bare its teeth,” says Kate Marshall of Hargreaves Lansdown. In 2008 China accounted for 15% of the emerging market stock index, but its shares have since risen to one-third. “Chinese middle and upper income groups are forecast to expand by over a third of a billion people by 2030,” roughly equivalent to the US population. Not for the first time, Asia looks set to be the “engine of global growth”.
Chinese stocks had a terrible 2021
Despite that, “Chinese stocks had a terrible 2021”, says Jacky Wong in The Wall Street Journal. A regulatory crackdown on education and tech stocks – “Alibaba lost nearly half of its market value in 2021” – combined with a slowing property market saw the large-cap CSI 300 index finish last year down 5%.
Yet 2022 may be better. While most central banks hike interest rates, China has eased monetary policy in recent months to cushion the effects of the property downturn. That should provide a “tailwind” to equities, which look cheap: on 12.1 times forecast earnings, the MSCI China index trades below its five-year average valuation.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Wall Street is almost entirely bullish, agrees Sofia Horta e Costa on Bloomberg. Marko Kolanovic of JPMorgan forecasts that the MSCI China index will “surge almost 40%” this year. “That bet isn’t going so well.” The CSI 300 fell 7% in January and entered a bear market, having fallen 20% since a February 2021 peak.
The ongoing property market fallout, earnings downgrades and Omicron restrictions are keeping the market subdued for now, says Sean Taylor of DWS. But come the second quarter “targeted government support” will boost growth and should see stocks start to outperform.
Big tech is out of favour
China may also dodge the West’s Covid-19 hangover. While debt has soared elsewhere during the crisis, China’s non-financial-sector debt fell by 7% to 265% of gross domestic product by the third quarter of last year. The “de-leveraging” campaign that has hit the property sector is bearing fruit. “In the last Year of the Tiger, 12 years ago, China successfully overtook Japan as the world’s second-largest economy.” This year could bring a similar leap in markets.
The upcoming Winter Olympics and a busy political year should see Beijing prioritise stability in 2022, says Reshma Kapadia in Barron’s. That “lowers the odds of further dramatic regulatory crackdowns”. Still, “the online businesses, e-commerce companies and gaming” stocks that dominated the last decade are now out of favour, says Pradipta Chakrabortty of investment manager Harding Loevner. Instead, the climate favours smaller firms in sectors such as industrials, healthcare and IT, says Kapadia.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Was Margaret Thatcher great for Britain?
The 'Iron Lady’ would be celebrating her 100th birthday this month. Margaret Thatcher rose to power in 1979 as the first ever female prime minister and was one of the most controversial leaders in history, but how did her policies shape today’s finances?
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?